Selections from The Scientist’s reading list:

  • ProPublica this week (February 16) has the story behind The Wall Street Journal’s October 2015 article investigating the blood-testing startup Theranos, which is facing scrutiny by the US Centers for Medicare and Medicaid Services and other agencies. “I’ve heard, and pretty much ascertained during my reporting, that the company did not offer any information about the science, and about how the technology worked, about how its laboratory instrument worked, or about its financials,” the Wall Street Journal’s John Carreyou told ProPublica. “So investors who were ponying up this money were, for the most part, going in blind.”
  • Researchers, funding agencies, and publishers are agreeing to freely share data related to the ongoing Zika virus epidemic. While it’s undoubtedly a step in the right direction, The Scientist’s Kerry Grens noted last week (February 10): “How about...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?